Final results were consistent with previously conducted research in patients with advanced renal cell carcinoma treated with ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

Nivolumab was first evaluated in a phase I ... with 52% of participants achieving a complete response. No grade 3/4 side effects were observed (Westin et al, 2010). Patients with heavily ...